Odyssey Therapeutics (ODTX) Earnings Analysis
Odyssey Therapeutics (ODTX) next reports earnings on 2026-09-16, consensus EPS -0.91214 USD. Last quarter (2026-06-17) it missed with EPS -6.77 USD vs -1.11349 USD est (-508%). It has beaten estimates in 0/1 recent quarters (0%). Trailing P/E -3.45.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ODTX next report earnings?
| Next earnings date | 2026-09-16 |
|---|---|
| Consensus EPS estimate | -0.91214 USD |
| Revenue estimate | n/a |
ODTX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-06-17 | -6.77 USD | -1.11349 USD | -508% | Miss |
Beat rate: 0/1 (0%) over reported quarters with consensus data.
ODTX valuation and analyst view
| Trailing P/E | -3.45 |
|---|---|
| Trailing EPS | -5.39335 USD |
| Price / book | -1.05 |
| Dividend yield | 0.00% |
| Market cap | 0.55B |
| Analyst consensus | Buy (1 buy / 0 hold / 0 sell) |
| Avg price target | 35 USD |
Related research pages
Frequently asked questions
When is Odyssey Therapeutics (ODTX)'s next earnings date?
Odyssey Therapeutics is next scheduled to report on 2026-09-16, with a consensus EPS estimate of -0.91214 USD.
Did ODTX beat earnings last quarter?
In its 2026-06-17 report, ODTX posted EPS of -6.77 USD versus a -1.11349 USD estimate — a miss of 508%.
What is ODTX's earnings track record?
Over the last 1 reported quarters with consensus data, ODTX beat estimates 0 times (0%).
What is ODTX's current P/E ratio and EPS?
ODTX trades at a trailing P/E of -3.45 on trailing EPS of -5.393346141927217 USD.
What do analysts rate ODTX?
Analyst consensus is "Buy" across 1 ratings (0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 35 USD.